drugset / Trial / NCT01118273

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine

NCT01118273

Phase 4 Completed 162 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of the study are to evaluate the analgesic and hypnotic efficacy of naproxen sodium and diphenhydramine combination when compared to naproxen sodium, diphenhydramine, and an ibuprofen and diphenhydramine combination

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown 50 mg Oral
Comparator Diphenhydramine Unknown 76 mg Oral
Comparator Ibuprofen Small molecule 400 mg Oral
Subject Naproxen Small molecule 220 mg Oral
Subject Naproxen Small molecule 440 mg Oral

Indications

No indication recorded.